Affiliation:
1. From the Department of Pathology, Cooper University Hospital, Cooper Medical School of Rowan University, Camden, New Jersey
Abstract
Context.—
Appropriate patient management requires precise and meaningful tumor classification. Breast cancer classification continues to evolve from traditional morphologic evaluation to more sophisticated systems with the integration of new knowledge from research being translated into practice. Breast cancer is heterogeneous at the molecular level, with diversified patterns of gene expression, which is presumably responsible for the difference in tumor behavior and prognosis. Since the beginning of this century, new molecular technology has been gradually applied to breast cancer research on issues pertinent to prognosis (prognostic signature) and therapeutic prediction (predictive signature), and much progress has been made.
Objective.—
To summarize the current state and the prospective future of molecular classification of breast cancer.
Data Sources.—
Sources include recent medical literature on molecular classification of breast cancer.
Conclusions.—
Identification of intrinsic tumor subtypes has set a foundation for refining the breast cancer molecular classification. Studies have explored the genetic features within the intrinsic cancer subtypes and have identified novel molecular targets that led to the innovation of clinical assays to predict a patient's prognosis and to provide specific guidelines for therapeutic decisions. With the development and implication of these molecular tools, we have remarkably advanced our knowledge and enhanced our power to provide optimal management to patients. However, challenges still exist. Besides accurate prediction of prognosis, we are still in urgent need of more molecular predictors for tumor response to therapeutic regimes. Further exploration along this path will be critical for improving a patient's prognosis.
Publisher
Archives of Pathology and Laboratory Medicine
Subject
Medical Laboratory Technology,General Medicine,Pathology and Forensic Medicine
Reference68 articles.
1. WHO Classification of Tumors, Breast Tumors. 5th ed.
Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer;2019.
2. Perou
CM,
Sorlie
T,
Eisen
MB,
et al.
Molecular portraits of human breast tumors.
Nature.
2000;
406(6796):
747–
752.
3. Sorlie
T,
Perou
CM,
Tibshirani
R,
Aas
T,
et al.
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
Proc Natl Acad Sci U S A.
2001;
98(19):
10869–
10874.
4. Sorlie
T,
Tibshirani
R,
Parker
J,
et al.
Repeated observation of breast tumor subtypes in independent gene expression data sets.
Proc Natl Acad Sci U S A.
2003;
100(14):
8413–
8432.
5. Cheang
MCU,
van de Riin
M,
Nielsen
TO.
Gene expression profiling of breast cancer.
Annu Rev Pathol Mech Dis.
2008;
3:
67–
97.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献